from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv1085c/-

LFCtreatmentdescriptionclass of inhibitor

0.000

Amikacinug/mL Amikacintranslation

0.377

Cap5-10ug/mL Capreomycintranslation

0.824

Rox10-50 ug/mL Roxithromycintranslation

0.000

SM2-5 ug/mL Streptomycintranslation

0.000

Tet5-10 ug/mL Tetracyclinetranslation

-0.026

Rif0.2-5ug/mL Rifampicintranscription

0.438

Rifp0.1-0.5ug/mL Rifapentinetranscription

0.335

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-1.738

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.326

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.303

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.187

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-1.573

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-2.203

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-0.778

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.637

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.505

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.405

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-1.544

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

0.094

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-1.664

KCN5-20 ug/mL Potassium cyaniderespiration

-0.300

NaN30.2-2 mM Sodium aziderespiration

-0.426

Nigericin50 uM Nigericinrespiration

-0.447

TRC10-150 ug/mL Triclosanrespiration

-1.034

TRZ10-25 ug/mL Thioridazinerespiration

-0.841

Valinomycin0.5-10 uM Valinomycinrespiration

0.491

ZnSO42 mM ZnSO4respiration

-0.280

menadione6-10 ug/mL Menadionerespiration

0.376

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.724

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.503

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.149

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

0.120

NRP_1Non-replicating persistence stage 1dosRassociated

0.000

Amp0.2mg/mL AmpicillincellWall

0.350

Cephalexin20-100 ug/mL CephalexincellWall

0.348

Cerulenin0.32-5 ug/mL CerulenincellWall

0.010

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.244

EMB10-20 ug/mL EthambutolcellWall

0.983

Eta12-40 ug/mL EthionamidecellWall

0.092

INH0.2-0.4 ug/mL IsoniazidcellWall

0.000

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.086

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.141

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.088

BZA0.12 mg/mL BenzamidearomaticAmides

0.005

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.644

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.251

H2O24 mM hydrogen peroxideDNAdamaging

0.000

Levo10 ug/mL LevofloxacinDNAdamaging

0.592

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-1.947

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.000

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.658

UVUV-irradiationDNAdamaging

-0.309

ARP41-4 ug/mL Antitubercular compound ARP4?

1.307

Antimycin12.5-50 ug/mL Antimycin A?

-0.196

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

1.239

PA_110-50 ug/mL Antitubercular compound PA-1?

1.212

PA_2110-50 ug/mL Antitubercular compound PA-21?

-1.039

PA8240.2-2 ug/mL PA-824?

-0.089

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.173

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.066

Verapamil50 uM Verapamil?

-0.156

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.049

methoxatin10-20 ug/mL Methoxatin?